Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep57 | (1) | SFEBES2016

Co-existent macro-prolactinoma, raised free T4 and right sided facial nerve palsy

Gohil Shailesh , Bhake Ragini , Reddy Narendra , Levy Miles

Background: Pituitary adenomas commonly present with palsies involving the cranial nerves in the cavernous sinus. It is unusual, however, for other cranial nerve palsies to co-present and to have biochemical results that do not fit with the clinical picture.Case: A 47 year old man was admitted with 3 days of headache, vomiting, right sided facial paraesthesia and facial droop. He had no symptoms suggestive of endocrine disturbance. Neurological examinati...

ea0059p079 | Clinical practice, governance & case reports | SFEBES2018

Thyroid shared care – a nurse-led, virtual service for our patients

Gohil Shailesh , Kieffer Veronica , Bremner Emma , Robinson Carole , Levy Miles

Background: A large proportion of patients who attend the Endocrine clinic have thyroid dysfunction, usually thyrotoxicosis. These patients require regular thyroid function tests (TFTs) and advice on medication dose alteration, usually through frequent clinic appointments. At our University Teaching Hospital, we have a nurse-led system whereby TFT monitoring and advice is managed virtually, with patients usually attending clinic annually for review. We call this the Thyroid Sh...

ea0072p5 | (1) | UKINETS2020

Allelic deletion of chromosome 18 is common in intra-abdominal neuroendocrine neoplasms

Gohil Shailesh , Hastings Rob , Shaw Jacqui , Levy Miles

Introduction: Our knowledge of the genomic background of neuroendocrine neoplasms (NENs) is rapidly expanding with more widespread use of sequencing technologies. Although known to be mutationally quiet compared to some other malignancies, many NENs harbour somatic copy number alterations (SCNAs), however the significance of these are unclear.Aims: We sought to identify SCNAs in a cohort of patients with NENs.Methods: Whole exome s...

ea0094p51 | Innovation in Teaching | SFEBES2023

Genomic notes for clinicians – A genomic testing resource for endocrinologists

Gohil Shailesh , Korbonits Marta , Casey Ruth , Newey Paul , Levy Miles

Introduction: Genomic testing is expected to become a part of mainstream testing in the not-too-distant future, with clinicians ordering genetics tests in the same way routine endocrine tests are requested today. Knowledge on how and what test to request needs to be gathered by a wide range of physicians. To support this, the Genomics Education Programme of NHS England is developing a resource for all endocrinologists to use in clinic as part itÂ’s Genomic...

ea0104p203 | Thyroid | SFEIES24

Liothyronine prescribing at university hospitals of leicester NHS trust – audit (2nd cycle)

Al Jumaah Ali , Levy Miles , Gohil Shailesh , Reddy Narendra

Despite that the standard treatment for hypothyroidism is Levothyroxine, it is now recognised that a certain group of patients would benefit from treatment with Liothyronine either alone or in combination with Levothyroxine. Compared to Levothyroxine, Liothyronine has shorter-half life and can be associated with less predictable biochemical outcomes. In 2021, we published the outcome of the 1 st cycle of audit of use of Liothyronine at the University Hospital of Lei...

ea0104p16 | Adrenal & Cardiovascular | SFEIES24

A forgotten relation between adrenal insufficiency and auricular petrification

Ahsan Masato , Levy Miles , Reddy Narendra , Gohil Shailesh

Background: Calcification or ossification of the auricular cartilage, known as "petrified ears," is a rare condition typically linked to local trauma, frostbite, or inflammation. Endocrinopathies, especially adrenal insufficiency, has been historically linked with this condition. There are several reports of its association with different causes of primary adrenal insufficiency but only a very few reported cases of secondary adrenal insufficiency leading to bilateral auricular...

ea0077cc5 | (1) | SFEBES2021

Transformation of a non-functional to a functional neuroendocrine tumour

Gohil Shailesh , Reddy Narendra , Levy Miles , Kamil Anver , Richards Cathy , Bhake Ragini

Case: A 69 year old man was diagnosed with poorly differentiated pancreatic adenocarcinoma with liver metastases in November 2017 and received FOLFIRINOX chemotherapy followed by Gemcitabine. This stabilised his disease and chemotherapy was stopped in March 2020. In April 2021 he presented with a 3-4 month history of tiredness; intermittent confusion, especially in the early morning; the discovery that food resolved his symptoms, albeit temporarily; and accompanying significan...

ea0077p221 | Neuroendocrinology and Pituitary | SFEBES2021

The usefulness of measuring neurone specific enolase in patients seen in the Endocrine Clinic

Gohil Shailesh , Jumaah Ali Al , Rahman Faizanur , Reddy Narendra , Bhake Ragini , Levy Miles

Introduction: There is a clinical need to develop better biomarkers for the monitoring of patients with neuroendocrine tumours (NETs), including for patients with multiple endocrine neoplasia (MEN). Chromogranins are widely used, as are individual hormones for specific syndromes. Neurone specific enolase (NSE), however, is measured less commonly and its utility is debatable.Aims: To assess the value of measuring NSE in the clinical management of patients...

ea0080OC2 | Oral Communications | UKINETS2021

Tracking circulating cell free tumour derived DNA in patients with neuroendocrine neoplasms

Gohil Shailesh , Page Karen , Hastings Rob , Iwuji Chinenye , Richards Cathy , Shaw Jacqui , Levy Miles

Introduction: There is a clinical need to develop novel and better biomarkers to monitor patients with neuroendocrine neoplasms (NENs). Our aim was to identify and track plasma circulating cell free tumour derived DNA (ctDNA) in a cohort of patients using a personalised, patient specific approach.Materials and methods: 35 serial plasma samples were collected from 9 patients with metastatic NENs (6 small intestinal and 1 each of lung, ovarian, and pelvic;...

ea0081p383 | Endocrine-Related Cancer | ECE2022

Circulating cell-free tumour DNA (ctDNA) utilisation in diagnosis and monitoring of thyroid cancer response to treatment - systematic review

Al Jumaah Ali , Levy Miles J , Reddy Narendra , Bhake Ragini , Gohil Shailesh

Thyroid cancer is the most common endocrine malignancy accounting for 1% of new cancer cases each year. Even after treatment, one in five patients develop recurrence eventually. Therefore, close follow up is crucial after treatment. Current tumour biomarkers are not perfect, and there is a need for a more sensitive and specific way of detecting early recurrence. Liquid biopsies have emerged as a novel marker in tumour surveillance and monitoring response to treatment. In parti...